Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Shah, Parita
Iwata, Yusuke
Brown, Eric E.
Kim, Julia
Sanches, Marcos
Takeuchi, Hiroyoshi
Nakajima, Shinichiro
Hahn, Margaret
Remington, Gary
Gerretsen, Philip
and
Graff-Guerrero, Ariel
2020.
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 270,
Issue. 1,
p.
11.
de Filippis, Renato
Gaetano, Raffaele
Schoretsanitis, Georgios
Verde, Giuseppe
Oliveti, Cesare Anthony
Kane, John M
Segura-Garcia, Cristina
and
De Fazio, Pasquale
2021.
Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile.
Neuropsychiatric Disease and Treatment,
Vol. Volume 17,
Issue. ,
p.
2141.
Lally, John
Breese, Emily
Osman, Mugtaba
Hua Sim, Cai
Shetty, Hitesh
Krivoy, Amir
and
MacCabe, James H.
2021.
Augmentation of clozapine with ECT: a retrospective case analysis.
Acta Neuropsychiatrica,
Vol. 33,
Issue. 1,
p.
31.
Béchard, Laurent
Corbeil, Olivier
Malenfant, Esthel
Lehoux, Catherine
Stip, Emmanuel
Roy, Marc-André
and
Demers, Marie-France
2021.
Une approche de la psychopharmacologie des premiers épisodes psychotiques axée sur le rétablissement.
Santé mentale au Québec,
Vol. 46,
Issue. 2,
p.
113.
Morimoto, Yoshiro
Kanegae, Shinji
and
Ozawa, Hiroki
2021.
NeuroPsychopharmacotherapy.
p.
1.
Seppälä, Annika
Pylvänäinen, Jenni
Lehtiniemi, Heli
Hirvonen, Noora
Corripio, Iluminada
Koponen, Hannu
Seppälä, Jussi
Ahmed, Anthony
Isohanni, Matti
Miettunen, Jouko
and
Jääskeläinen, Erika
2021.
Predictors of response to pharmacological treatments in treatment-resistant schizophrenia – A systematic review and meta-analysis.
Schizophrenia Research,
Vol. 236,
Issue. ,
p.
123.
Chakrabarti, Subho
2021.
Clozapine resistant schizophrenia: Newer avenues of management.
World Journal of Psychiatry,
Vol. 11,
Issue. 8,
p.
429.
Meltzer, Herbert Y.
and
Gadaleta, Erick
2021.
Contrasting Typical and Atypical Antipsychotic Drugs.
Focus,
Vol. 19,
Issue. 1,
p.
3.
Pardiñas, Antonio F.
Owen, Michael J.
and
Walters, James T.R.
2021.
Pharmacogenomics: A road ahead for precision medicine in psychiatry.
Neuron,
Vol. 109,
Issue. 24,
p.
3914.
Yang, So Yung
Choi, Jung-Kyu
Park, Sunyoung
and
Park, Jaesub
2021.
Effect of Delayed Clozapine Initiation on Acute Treatment Response in Treatment-Resistant Schizophrenia.
Korean Journal of Schizophrenia Research,
Vol. 24,
Issue. 2,
p.
52.
Cummings, Michael A.
and
O’Day, Jennifer A.
2021.
Should electroconvulsive therapy (ECT) be banned for schizophrenia?.
CNS Spectrums,
p.
1.
Rosson, Stella
de Filippis, Renato
Croatto, Giovanni
Collantoni, Enrico
Pallottino, Simone
Guinart, Daniel
Brunoni, Andre R.
Dell’Osso, Bernardo
Pigato, Giorgio
Hyde, Joshua
Brandt, Valerie
Cortese, Samuele
Fiedorowicz, Jess G.
Petrides, Georgios
Correll, Christoph U.
and
Solmi, Marco
2022.
Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review.
Neuroscience & Biobehavioral Reviews,
Vol. 139,
Issue. ,
p.
104743.
Fonseca de Freitas, Daniela
Kadra-Scalzo, Giouliana
Agbedjro, Deborah
Francis, Emma
Ridler, Isobel
Pritchard, Megan
Shetty, Hitesh
Segev, Aviv
Casetta, Cecilia
Smart, Sophie E
Downs, Johnny
Christensen, Søren Rahn
Bak, Nikolaj
Kinon, Bruce J
Stahl, Daniel
MacCabe, James H
and
Hayes, Richard D
2022.
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.
Journal of Psychopharmacology,
Vol. 36,
Issue. 4,
p.
498.
Markiewicz, Renata
Markiewicz-Gospodarek, Agnieszka
and
Dobrowolska, Beata
2022.
Galvanic Skin Response Features in Psychiatry and Mental Disorders: A Narrative Review.
International Journal of Environmental Research and Public Health,
Vol. 19,
Issue. 20,
p.
13428.
Kambeitz-Ilankovic, Lana
Koutsouleris, Nikolaos
and
Upthegrove, Rachel
2022.
The potential of precision psychiatry: what is in reach?.
The British Journal of Psychiatry,
Vol. 220,
Issue. 4,
p.
175.
Jongkind, Amy
Hendriks, Michelle
Grootens, Koen
Beekman, Aartjan T F
and
van Meijel, Berno
2022.
Evaluation of a Collaborative Care Program for Patients With Treatment-Resistant Schizophrenia: Protocol for a Multiple Case Study.
JMIR Research Protocols,
Vol. 11,
Issue. 6,
p.
e35336.
Kadra-Scalzo, Giouliana
Fonseca de Freitas, Daniela
Agbedjro, Deborah
Francis, Emma
Ridler, Isobel
Pritchard, Megan
Shetty, Hitesh
Segev, Aviv
Casetta, Cecilia
Smart, Sophie E.
Morris, Anna
Downs, Johnny
Christensen, Søren Rahn
Bak, Nikolaj
Kinon, Bruce J.
Stahl, Daniel
Hayes, Richard D.
MacCabe, James H.
and
Hori, Hikaru
2022.
A predictor model of treatment resistance in schizophrenia using data from electronic health records.
PLOS ONE,
Vol. 17,
Issue. 9,
p.
e0274864.
Borovcanin, Milica M.
Milovanovic, Marija
Vesic, Katarina
Muric, Nemanja N.
Milovanovic, Jelena
Arsenijevic, Aleksandar N.
and
Arsenijevic, Nebojsa N.
2022.
Translational Autoimmunity.
p.
343.
Caqueo-Urízar, Alejandra
Ponce-Correa, Felipe
Semir-González, Carla
and
Urzúa, Alfonso
2022.
Latent Profiles of Premorbid Adjustment in Schizophrenia and Their Correlation with Measures of Recovery.
Journal of Clinical Medicine,
Vol. 11,
Issue. 13,
p.
3840.
Morimoto, Yoshiro
Kanegae, Shinji
and
Ozawa, Hiroki
2022.
NeuroPsychopharmacotherapy.
p.
1709.